Grace Therapeutics
GRCE
#9700
Rank
A$82.54 M
Marketcap
A$5.33
Share price
3.24%
Change (1 day)
-17.39%
Change (1 year)

Earnings for Grace Therapeutics (GRCE)

Earnings in 2025 (TTM): -A$14.8 Million

According to Grace Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$24.56 Million, an increase over its 2023 earnings that were of -A$72.57 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Grace Therapeutics from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$14.8 Million-39.74%
2024 -A$24.56 Million-66.16%
2023 -A$72.57 Million161.72%
2022 -A$27.73 Million60.58%
2021 -A$17.27 Million-462.11%
2020 A$4.76 M
2018 -A$37.56 Million
2015 -A$6.1 Million
2013 -A$14.81 Million49.55%
2012 -A$9.91 Million